X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (351) 351
lisdexamfetamine dimesylate (347) 347
humans (342) 342
psychiatry (234) 234
attention deficit disorder with hyperactivity - drug therapy (225) 225
double-blind (223) 223
attention-deficit/hyperactivity disorder (196) 196
male (190) 190
adhd (183) 183
pharmacology & pharmacy (179) 179
female (171) 171
central nervous system stimulants - therapeutic use (162) 162
methylphenidate (157) 157
lisdexamfetamine (149) 149
children (143) 143
attention-deficit hyperactivity disorder (142) 142
deficit hyperactivity disorder (142) 142
adult (140) 140
attention deficit hyperactivity disorder (139) 139
treatment outcome (130) 130
child (129) 129
adolescent (121) 121
efficacy (111) 111
dextroamphetamine - therapeutic use (109) 109
central nervous system stimulants - adverse effects (106) 106
drug therapy (98) 98
clinical neurology (95) 95
adults (90) 90
safety (86) 86
neurosciences (82) 82
dextroamphetamine - adverse effects (81) 81
central nervous system stimulants - administration & dosage (80) 80
double-blind method (79) 79
adolescents (77) 77
amphetamine (73) 73
atomoxetine (71) 71
pharmacotherapy (69) 69
dose-response relationship, drug (67) 67
medicine & public health (64) 64
dextroamphetamine - administration & dosage (61) 61
stimulants (61) 61
hyperactivity (60) 60
middle aged (60) 60
lisdexamfetamine dimesylate - therapeutic use (59) 59
open-label (59) 59
pediatrics (59) 59
psychopharmacology (56) 56
young adult (56) 56
care and treatment (54) 54
analysis (53) 53
methylphenidate - therapeutic use (51) 51
attention deficit disorder with hyperactivity - psychology (50) 50
placebo-controlled trial (50) 50
research (48) 48
amphetamines (45) 45
extended-release (45) 45
teenagers (44) 44
clinical trials (43) 43
oros methylphenidate (43) 43
animals (41) 41
neurology (41) 41
pharmacokinetics (41) 41
pharmacology (40) 40
psychology, developmental (40) 40
salts extended-release (40) 40
deficit/hyperactivity disorder (38) 38
dosage and administration (38) 38
medicine, general & internal (38) 38
prevalence (38) 38
dimesylate (37) 37
attention deficit disorder with hyperactivity - diagnosis (36) 36
comorbidity (36) 36
deficit-hyperactivity disorder (35) 35
psychiatric status rating scales (34) 34
stimulant (34) 34
central nervous system stimulants - pharmacology (33) 33
mixed amphetamine salts (33) 33
original (33) 33
drugs (32) 32
internal medicine (32) 32
dextroamphetamine (31) 31
mental disorders (31) 31
quality-of-life (31) 31
studies (31) 31
health aspects (30) 30
hyperactivity disorder (30) 30
randomized controlled trials as topic (30) 30
attention deficit disorder with hyperactivity - physiopathology (29) 29
binge-eating disorder - drug therapy (29) 29
d-amphetamine (29) 29
diagnosis (29) 29
lisdexamfetamine dimesylate - adverse effects (29) 29
atomoxetine hydrochloride (28) 28
children & youth (28) 28
controlled-trial (28) 28
dextroamphetamine - pharmacokinetics (28) 28
dextroamphetamine - pharmacology (28) 28
psychology, clinical (28) 28
methylphenidate - adverse effects (27) 27
abridged index medicus (26) 26
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Drugs, ISSN 0012-6667, 07/2018, Volume 78, Issue 10, pp. 1025 - 1036
Lisdexamfetamine dimesylate (lisdexamfetamine; Elvanse (R); Tyvense (R)), an orally-active dexamfetamine prodrug, is indicated in the EU for the treatment of... 
PHARMACOLOGICAL-TREATMENT | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | LONG-ACTING STIMULANTS | DEFICIT HYPERACTIVITY DISORDER | FUNCTIONAL OUTCOMES | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | GUANFACINE EXTENDED-RELEASE | TOXICOLOGY | QUALITY-OF-LIFE | HEAD-TO-HEAD | RANDOMIZED-WITHDRAWAL | Dextroamphetamine - pharmacology | Drug Administration Schedule | Europe | Humans | Dextroamphetamine - therapeutic use | Methylphenidate - pharmacology | Treatment Outcome | Drug Approval | Attention Deficit Disorder with Hyperactivity - drug therapy | Lisdexamfetamine Dimesylate - pharmacokinetics | Dose-Response Relationship, Drug | Central Nervous System Stimulants - therapeutic use | Central Nervous System Stimulants - adverse effects | Central Nervous System Stimulants - pharmacokinetics | Lisdexamfetamine Dimesylate - adverse effects | Methylphenidate - therapeutic use | Quality of Life | Lisdexamfetamine Dimesylate - therapeutic use | Central Nervous System Stimulants - administration & dosage | Child | Lisdexamfetamine Dimesylate - administration & dosage | Urine | Appetite | Headache | Hyperactivity | Attention deficit hyperactivity disorder | Pharmacology | Quality of life | Children & youth | Studies | Sleep disorders | Stimulants | Metabolites | Insomnia | Weight reduction | Teenagers | Children | Adolescents | Drug therapy | Psychiatry | Methylphenidate
Journal Article
Journal Article
International Journal of Eating Disorders, ISSN 0276-3478, 08/2017, Volume 50, Issue 8, pp. 884 - 892
Objective This study examined the time course of efficacy‐related endpoints for lisdexamfetamine dimesylate (LDX) versus placebo in adults with... 
time course | binge‐eating disorder | efficacy | lisdexamfetamine | binge-eating disorder | OBESITY | NUTRITION & DIETETICS | PSYCHIATRY | OBSESSIVE-COMPULSIVE SCALE | TOPIRAMATE | PSYCHOLOGY, CLINICAL | SIBUTRAMINE | PSYCHOLOGY | Original
Journal Article
Neuropsychopharmacology, ISSN 0893-133X, 04/2016, Volume 41, Issue 5, pp. 1251 - 1260
The efficacy and safety of lisdexamfetamine dimesylate (LDX) vs placebo in binge eating disorder (BED) was evaluated in two multicenter, double-blind,... 
ORLISTAT | EFFICACY | SAFETY | PSYCHIATRY | TOPIRAMATE | NEUROSCIENCES | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | OBESE-PATIENTS | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | PLACEBO-CONTROLLED TRIAL | AMPHETAMINE | SIBUTRAMINE | Original
Journal Article
Journal Article
Journal Article
The International journal of eating disorders, 08/2017, Volume 50, Issue 8, p. 884
This study examined the time course of efficacy-related endpoints for lisdexamfetamine dimesylate (LDX) versus placebo in adults with protocol-defined moderate... 
Central Nervous System Stimulants - pharmacology | Central Nervous System Stimulants - therapeutic use | Lisdexamfetamine Dimesylate - pharmacology | Double-Blind Method | Humans | Binge-Eating Disorder - drug therapy | Adult | Female | Male | Treatment Outcome | Lisdexamfetamine Dimesylate - therapeutic use
Journal Article
Journal of Psychopharmacology, ISSN 0269-8811, 6/2013, Volume 27, Issue 6, pp. 479 - 496
Amphetamine was discovered over 100 years ago. Since then, it has transformed from a drug that was freely available without prescription as a panacea for a... 
amphetamine | drug formulations | Abuse liability | microdialysis | attention deficit hyperactivity disorder (ADHD) | lisdexamfetamine | FREELY MOVING RATS | HEALTHY ADULT VOLUNTEERS | PSYCHIATRY | DEFICIT HYPERACTIVITY DISORDER | DOPAMINE TRANSPORTER OCCUPANCY | SALTS EXTENDED-RELEASE | NEUROSCIENCES | MINIMAL BRAIN-DYSFUNCTION | CLINICAL NEUROLOGY | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | MEDIAL PREFRONTAL CORTEX | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | LISDEXAMFETAMINE DIMESYLATE | Central Nervous System Stimulants - pharmacology | Dextroamphetamine - pharmacology | Prodrugs | Amphetamine - therapeutic use | Humans | Amphetamine - pharmacology | Dextroamphetamine - therapeutic use | Amphetamine - adverse effects | Attention Deficit Disorder with Hyperactivity - drug therapy | Dextroamphetamine - adverse effects | Animals | Central Nervous System Stimulants - therapeutic use | Lisdexamfetamine Dimesylate | Central Nervous System Stimulants - adverse effects | Amphetamine-Related Disorders - prevention & control | Adolescent | Drug Design | Adult | Amphetamine-Related Disorders - epidemiology | Narcolepsy - drug therapy | Child | Safety and security measures | Laws, regulations and rules | Attention-deficit hyperactivity disorder | Amphetamines | Chemical properties | Amphetamine abuse | Drug therapy | Risk factors | Review
Journal Article